RB GLOBAL INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that RB GLOBAL INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.59B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.28B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $3.68B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $1.73B | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $1.42B | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $383.41M | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | $331.54M | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $389.05M | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $273.26M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $332.19M | Feb 18, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $531.50M | Feb 26, 2018 |
| FY2018 | Dec 31, 2016 | $188.56M | Feb 28, 2019 |
| FY2017 | Dec 31, 2015 | $459.85M | Feb 26, 2018 |
| FY2016 | Dec 31, 2014 | $423.21M | Feb 21, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $428.40M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $413.10M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $206.50M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $319.70M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $151.90M | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $48.86M | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | $45.39M | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $53.04M | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $22.81M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $51.57M | Feb 18, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $713.40M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $761.20M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $471.30M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $453.50M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $241.00M | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $72.89M | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | $67.38M | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $88.80M | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $34.08M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $71.48M | Feb 18, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $905.20M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $773.90M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $743.70M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $539.90M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $456.20M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $410.29M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $382.39M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $382.68M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $323.27M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $283.53M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $978.20M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $932.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $544.00M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $463.10M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $317.60M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $257.87M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $332.79M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $144.28M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $147.57M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $177.56M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $259.00M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $167.40M | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $227.90M | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $32.00M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $9.80M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $14.26M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $13.59M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $16.86M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $10.81M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $18.92M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.14B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $11.81B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $12.04B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $2.86B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $3.59B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $2.35B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $2.23B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $2.05B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.02B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.60B | Feb 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.08B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $6.09B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $6.53B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.57B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.52B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.34B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $1.32B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $1.22B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.26B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $903.75M | Feb 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.57B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $5.22B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $5.02B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.29B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.07B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $1.01B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $901.83M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $830.64M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $739.68M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $687.06M | Feb 26, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.67B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $4.51B | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | $4.54B | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | $948.80M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $947.70M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $840.61M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $672.31M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $671.59M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $670.92M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $97.54M | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.25B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $1.09B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $918.50M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $1.04B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $839.61M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $791.92M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $714.05M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $648.26M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $602.61M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $601.07M | Feb 26, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $531.50M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $533.90M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $576.20M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $494.30M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $326.11M | Feb 21, 2023 |
| FY2022 | Dec 31, 2020 | $278.77M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $359.67M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $237.74M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $267.91M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $207.87M | Feb 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.33B | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | $2.63B | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | $3.08B | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | $581.50M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $1.74B | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | $636.65M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $645.48M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $711.30M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $812.89M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $595.71M | Feb 26, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 18, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 25, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 25, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 18, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 185.90M | Feb 25, 2026 |
| FY2025 | Dec 31, 2024 | 184.70M | Feb 25, 2026 |
| FY2024 | Dec 31, 2023 | 182.84M | Feb 26, 2025 |
| FY2023 | Dec 31, 2022 | 110.88M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 110.62M | Feb 21, 2023 |
| FY2021 | Dec 31, 2020 | 109.88M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | 109.34M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | 108.68M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 107.27M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 106.82M | Feb 26, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $206.00M | Feb 26, 2025 |
| FY2024 | Dec 31, 2023 | $298.00M | Feb 26, 2025 |
| FY2024 | Dec 31, 2022 | $115.20M | Feb 26, 2025 |
| FY2023 | Dec 31, 2021 | $103.80M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $91.74M | Feb 21, 2023 |
| FY2021 | Dec 31, 2019 | $82.54M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $75.68M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $72.79M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $70.46M | Feb 28, 2019 |
| FY2017 | Dec 31, 2015 | $64.34M | Feb 26, 2018 |